Breaking News

CordenPharma Colorado Leases Space at Flatiron Park Campus

Will house process development and analytical services for advanced peptide API production from development through commercialization.

Author Image

By: Charlie Sternberg

Associate Editor

CordenPharma Colorado, a peptide drug substance Contract Development and Manufacturing Organization (CDMO), has leased 64,000 square feet at Flatiron Park’s 5505 Central—Boulder’s first purpose-built speculative lab building—near the existing CordenPharma Colorado facility. Flatiron Park’s Boulder campus supports life science, quantum and technology tenants through resilient infrastructure, flexible building solutions, and a thoughtfully curated campus environment. CordenPharma Colorado...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters